CLINICAL_TRIALS
trial_result
· 2026-02-24
Clinical Trial Update: Pilot Study of Posaconazole in Crohn's Disease [Phase 4]
Summary
A Phase 4 pilot study of posaconazole in Crohn's disease with the CARD9 S12N risk allele was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cedars-Sinai Medical Center | Conditions: Crohn Disease, CARD9 S12N Risk Allele | Phase 4 | Status: TERMINATED | Results posted: 2026-02-24